Exposure to inorganic mercury in vivo attenuates extrinsic apoptotic signaling in Staphylococcal aureus enterotoxin B stimulated T-cells

Toxicology and Applied Pharmacology

Volumn 225, Issue 3, 2007, Pages 238-250

  Laiosa, Michael D ^a   Eckles, Kevin G ^a   Langdon, Margaret ^a   Rosenspire, Allen J ^b   McCabe Jr , Michael J ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Autoimmunity; Superantigens; T cells

Indexed keywords

CASPASE 3; CASPASE 8; CD69 ANTIGEN; ENTEROTOXIN; ENTEROTOXIN B; FAS ANTIGEN; MERCURIC CHLORIDE; MERCURY; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL ACTIVATION; CONTROLLED STUDY; FEMALE; IN VIVO STUDY; MERCURIALISM; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD95; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; APOPTOSIS; AUTOIMMUNITY; CASPASE 3; CASPASE 8; ENTEROTOXINS; FEMALE; GENE EXPRESSION REGULATION; MERCURIC CHLORIDE; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; T-LYMPHOCYTES; TIME FACTORS;

MUS;

EID: 36448940853     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.06.002     Document Type: Article

References (45)

1. Adachi M., Watanabe-Fukunaga R., and Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 1756-1760
2. Adachi M., Suematsu S., Kondo T., Ogasawara J., Tanaka T., Yoshida N., and Nagata S. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat. Genet. 11 (1995) 294-300
3. Adachi M., Suematsu S., Suda T., Watanabe D., Fukuyama H., Ogasawara J., Tanaka T., Yoshida N., and Nagata S. Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 2131-2136
4. Altman A. Abnormal antigen receptor-initiated signal transduction in lpr T lymphocytes. Semin. Immunol. 6 (1994) 9-17
5. Bagenstose L.M., Salgame P., and Monestier M. Murine mercury-induced autoimmunity: a model of chemically related autoimmunity in humans. Immunol. Res. 20 (1999) 67-78
6. Bidere N., Su H.C., and Lenardo M.J. Genetic disorders of programmed cell death in the immune system. Annu. Rev. Immunol. 24 (2006) 321-352
7. Bleesing J.J., Brown M.R., Straus S.E., Dale J.K., Siegel R.M., Johnson M., Lenardo M.J., Puck J.M., and Fleisher T.A. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood 98 (2001) 2466-2473
8. Clarkson T.W., and Magos L. The toxicology of mercury and its chemical compounds. Crit. Rev. Toxicol. 36 (2006) 609-662
9. Fontenot A.P., Newman L.S., and Kotzin B.L. Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP. Clin. Immunol. 100 (2001) 4-14
10. Herzenberg L.A., Tung J., Moore W.A., Herzenberg L.A., and Parks D.R. Interpreting flow cytometry data: a guide for the perplexed. Nat. Immunol. 7 (2006) 681-685
11. Hildeman D.A., Mitchell T., Teague T.K., Henson P., Day B.J., Kappler J., and Marrack P.C. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10 (1999) 735-744
12. Hildeman D.A., Zhu Y., Mitchell T.C., Bouillet P., Strasser A., Kappler J., and Marrack P. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 16 (2002) 759-767
13. Hultman P., Johansson U., and Dagnaes-Hansen F. Murine mercury-induced autoimmunity: the role of T-helper cells. J. Autoimmun. 8 (1995) 809-823
14. Hultman P., Turley S.J., Enestrom S., Lindh U., and Pollard K.M. Murine genotype influences the specificity, magnitude and persistence of murine mercury-induced autoimmunity. J. Autoimmun. 9 (1996) 139-149
15. Kawabe Y., and Ochi A. Selective anergy of V beta 8+,CD4+ T cells in Staphylococcus enterotoxin B-primed mice. J. Exp. Med. 172 (1990) 1065-1070
16. Kennedy N.J., Kataoka T., Tschopp J., and Budd R.C. Caspase activation is required for T cell proliferation. J. Exp. Med. 190 (1999) 1891-1896
17. Komoriya A., Packard B.Z., Brown M.J., Wu M.L., and Henkart P.A. Assessment of caspase activities in intact apoptotic thymocytes using cell-permeable fluorogenic caspase substrates. J. Exp. Med. 191 (2000) 1819-1828
18. Krueger A., Fas S.C., Baumann S., and Krammer P.H. The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol. Rev. 193 (2003) 58-69
19. Lawrence D.A., and McCabe Jr. M.J. Immunomodulation by metals. Int. Immunopharmacol. 2 (2002) 293-302
20. Marrack P., Blackman M., Kushnir E., and Kappler J. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J. Exp. Med. 171 (1990) 455-464
21. Martin D.A., Zheng L., Siegel R.M., Huang B., Fisher G.H., Wang J., Jackson C.E., Puck J.M., Dale J., Straus S.E., Peter M.E., Krammer P.H., Fesik S., and Lenardo M.J. Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 4552-4557
22. McCabe Jr. M.J., Whitekus M.J., Hyun J., Eckles K.G., McCollum G., and Rosenspire A.J. Inorganic mercury attenuates CD95-mediated apoptosis by interfering with formation of the death inducing signaling complex. Toxicol. Appl. Pharmacol. 190 (2003) 146-156
23. McCabe Jr. M.J., Eckles K.G., Langdon M., Clarkson T.W., Whitekus M.J., and Rosenspire A.J. Attenuation of CD95-induced apoptosis by inorganic mercury: caspase-3 is not a direct target of low levels of Hg2+. Toxicol. Lett. 155 (2005) 161-170
24. Misra R.S., Jelley-Gibbs D.M., Russell J.Q., Huston G., Swain S.L., and Budd R.C. Effector CD4+ T cells generate intermediate caspase activity and cleavage of caspase-8 substrates. J. Immunol. 174 (2005) 3999-4009
25. Monestier M., Losman M.J., Novick K.E., and Aris J.P. Molecular analysis of mercury-induced antinucleolar antibodies in H-2S mice. J. Immunol. 152 (1994) 667-675
26. Muraille E., De Smedt T., Andris F., Pajak B., Armant M., Urbain J., Moser M., and Leo O. Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by V beta-unrestricted T cell unresponsiveness and defective antigen-presenting cell functions. J. Immunol. 158 (1997) 2638-2647
27. Overton W.R. Modified histogram subtraction technique for analysis of flow cytometry data. Cytometry 9 (1988) 619-626
28. Pollard K.M., Lee D.K., Casiano C.A., Bluthner M., Johnston M.M., and Tan E.M. The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties. J. Immunol. 158 (1997) 3521-3528
29. Pollard K.M., Pearson D.L., Bluthner M., and Tan E.M. Proteolytic cleavage of a self-antigen following xenobiotic-induced cell death produces a fragment with novel immunogenic properties. J. Immunol. 165 (2000) 2263-2270
30. Potolicchio I., Mosconi G., Forni A., Nemery B., Seghizzi P., and Sorrentino R. Susceptibility to hard metal lung disease is strongly associated with the presence of glutamate 69 in HLA-DP beta chain. Eur. J. Immunol. 27 (1997) 2741-2743
31. Rieux-Laucat F., Fischer A., and Deist F.L. Cell-death signaling and human disease. Curr. Opin. Immunol 15 (2003) 325-331
32. Siegel R.M., Muppidi J., Roberts M., Porter M., and Wu Z. Death receptor signaling and autoimmunity. Immunol. Res. 27 (2003) 499-512
33. Sneller M.C., Dale J.K., and Straus S.E. Autoimmune lymphoproliferative syndrome. Curr. Opin. Rheumatol. 15 (2003) 417-421
34. Su H., Bidere N., Zheng L., Cubre A., Sakai K., Dale J., Salmena L., Hakem R., Straus S., and Lenardo M. Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 307 (2005) 1465-1468
35. Sun M., Ames K.T., Suzuki I., and Fink P.J. The cytoplasmic domain of Fas ligand costimulates TCR signals. J. Immunol. 177 (2006) 1481-1491
36. Takeuchi K., Turley S.J., Tan E.M., and Pollard K.M. Analysis of the autoantibody response to fibrillarin in human disease and murine models of autoimmunity. J. Immunol. 154 (1995) 961-971
37. te Boekhorst P.A., Barrera P., Laan R.F., and van de Putte L.B. Hepatotoxicity of parenteral gold therapy in rheumatoid arthritis: a case report and review of the literature. Clin. Exp. Rheumatol. 17 (1999) 359-362
38. Vabulas R., Bittlingmaier R., Heeg K., Wagner H., and Miethke T. Rapid clearance of the bacterial superantigen staphylococcal enterotoxin B in vivo. Infect. Immun. 64 (1996) 4567-4573
39. Vasseur F., Le Campion A., Pavlovitch J.H., and Penit C. Distribution of cycling T lymphocytes in blood and lymphoid organs during immune responses. J. Immunol. 162 (1999) 5164-5172
40. Verwilghen J., Kingsley G.H., Gambling L., and Panayi G.S. Activation of gold-reactive T lymphocytes in rheumatoid arthritis patients treated with gold. Arthritis Rheum. 35 (1992) 1413-1418
41. Warfvinge K., Hansson H., and Hultman P. Systemic autoimmunity due to mercury vapor exposure in genetically susceptible mice: dose-response studies. Toxicol. Appl. Pharmacol. 132 (1995) 299-309
42. Whitekus M.J., Santini R.P., Rosenspire A.J., and McCabe Jr. M.J. Protection against CD95-mediated apoptosis by inorganic mercury in Jurkat T cells. J. Immunol. 162 (1999) 7162-7170
43. Yang Y., Kim D., and Fathman C.G. Regulation of programmed cell death following T cell activation in vivo. Int. Immunol. 10 (1998) 175-183
44. Ziemba S.E., McCabe Jr. M.J., and Rosenspire A.J. Inorganic mercury dissociates preassembled Fas/CD95 receptor oligomers in T lymphocytes. Toxicol. Appl. Pharmacol. 206 (2005) 334-342
45. Ziemba S.E., Mattingly R.R., McCabe Jr. M.J., and Rosenspire A.J. Inorganic mercury inhibits the activation of LAT in T-cell receptor-mediated signal transduction. Toxicol. Sci. 89 (2006) 145-153